2Arnedos M, Smith I. Pregression of endocrine therapies for breast cancer [J]. Expert Rev Anticancer Ther,2007,7(11) : 1651-1664.
3Gonzalez-Angulo AM, Morales-Vasquzf, Horkobagyi GN. Overview of resistance to systemic therapy in patients with breast cancer [J]. Adv Exp Med Biol, 2007,608:1-22.
4Horwitz KB,Alexander PS. In site photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation [J]. Endocrinology, 1983, 113 (6) : 2195-2201.
5Jacobsen BM, Schittone SA, Richer JK, et al. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptorpositive breast cancer: PR isoform-specific gene regulation and tumor biology [J]. Mol Endocrinol, 2005,19 (3) : 574-587.
6Kariang A, Aupperlee MD, Haslam SZ. Progesterone receptor isoforms and proliferation in the rat mammary gland during development [J]. Endocrinology, 2007,148 (6) : 2723-2736.
7Balleine RL, Earls PJ, Webster LR. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma [J]. Int J Gynecol Pathol, 2004,23 (2) : 138-144.
8Brayman MJ, Julian J, Mulac-Jericervic B, et al. Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells[J]. Mol Endocrinol, 2006,20 (10) : 2278 - 2291.
9Flototto T, Niederacher D, Hohmann D, et al. Molecular mechanism of estrogen receptor (ER) alpha-specific, estradiol-dependent expression of the progesterone receptor (PR) B-isoform [J]. J Steroid Biochem Mol Biol, 2004,88 (2) : 131 - 142.
10Kun Yu, Chee How Lee. Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations [J]. Clin Cancer Res, 2004,10(16) : 5508-5517.
